Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.75
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: HSBC Shares Fall Amid Investec Downgrade

Wed, 08th Jul 2020 10:45

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.

----------

FTSE 100 - LOSERS

----------

HSBC, down 4.1%. Investec downgraded the bank to Hold from Buy.

----------

WPP, down 3.6%. Credit Suisse reinitiated coverage of the advertising giant with Underperform.

----------

FTSE 250 - WINNERS

----------

Pantheon International, up 1.2%. The private equity investor said it expects a slight rise in annual net asset value, outperforming one benchmark but falling short of another. The investor said its net asset value at the May 31 year-end was 2,882.8 pence, up 4.0% year-on-year from 2,770.6p. The 4.0% gain compares favourably to the FTSE All-Share Index which returned negative 11% during the period. Pantheon lagged behind the MSCI World Index which returned 7.4%, however.

----------

FTSE 250 - LOSERS

----------

FirstGroup, down 15%. The Aberdeen-headquartered public transport company posted a GBP299.6 million pretax loss for the year ended March 31, widened from a GBP97.9 million loss the year before. This was due to operating costs, which rose 11% to GBP7.91 billion from GBP7.12 billion and more than offset FirstGroup's revenue rise of 8.7% to GBP7.75 billion from GBP7.13 billion. This resulted in a swing to a GBP152.7 million operating loss from a GBP9.8 million profit. FirstGroup said this swing "reflects charges relating to the North American self-insurance provision, Greyhound impairment charges, restructuring and reorganisation costs and coronavirus-related charges". Finance costs also increased to GBP149.6 million from GBP110.4 million. In March, average passenger volumes fell by around 90% by month end amid lockdowns and school closures in North America.

----------

Victrex, down 5.2%. The polymers manufacturer said sales volume for its third quarter to June 30 was 805 tonnes, down 12% from 912 tonnes in the comparative period the year prior. Revenue was down 18% year-on-year to GBP58.8 million. The decline was attributed to the negative impact of the Covid-19 crisis. Sales volume from the start of the year to June 30 was broadly in line with the previous year. Revenue fell to GBP210.3 million from GBP217.8 million, reflecting a 3% decline. Victrex said the Aerospace, Automotive & Energy markets experienced the greatest level of decline. The deferral of elective procedures in Medical started to hurt performance from April as monthly revenue declines of 40% was recorded however, it added market indicators suggest that procedure deferral will gradually reverse. Looking ahead, the Lancashire-based company said with lower production levels reflecting weaker demand and inventory reduction, and consequently the under-absorption of fixed costs as well as a weaker mix, it expects its margin to be further hurt in the second half and into financial 2020.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Distil, up 17%. The owner of premium drinks brands RedLeg Spiced Rum, Blackwoods Gin and Vodka said unaudited year-on-year first quarter revenue grew by 21%, thanks to an increase in domestic retail sales both in store and on-line across our product range. Volumes were flat in the three months to the end of June year-on-year. Looking forward, Distil said its expectations for the six-month period to September versus the same period prior year are for revenue to increase by between 75% and 85%, which will allow increased marketing investment. Operating profit is expected in the range of GBP50,000 to GBP70,000. In the six months to the end of September 2019, the company reported operating profit of GBP1,000 on turnover of GBP824,000 and marketing costs of GBP219,000.

----------

Hurricane Energy, up 7.2%. The exploration & production company said the 205/21a-6 well on the Lancaster field, offshore UK, has produced at an average rate of 12,000 barrels of oil per day during the second quarter of 2020. The increase in oil production from the 205/21a-6 well implemented on June 5 has, as expected, been accompanied by an increase in produced water. The combined oil production from the 205/21a-6 and 205/21a-7z wells, however, was 1.3 million barrels in the second quarter of 2020, down slightly from 1.4 million barrels reported in the fist quarter. Following the relaxation of Covid-19 restraints on UK offshore operations, on Friday last week the company said it began commissioning the electric submersible pumps in the Lancaster production wells.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

E-Therapeutics, down 24% at 13.13 pence. The Oxford, England-based drug discovery company reported a closure of retail offer, raiding GBP750,000. The company said it issued 6.3 million shares at a price of 12p each. The shares were placed at a 31% discount to the closing mid-price on Monday, the latest practicable date prior to the time and date of retail offer announcement. The retail offer is a part of E-Therapeutics' plans to raise up to GBP12.4 million through placing, subscription, retail offer and broker option. The company said it will use the funds raised to facilitate a number of initiatives to enable its next stage of growth and value creation by expanding its platform capabilities and asset pipeline.

----------

boohoo, down 22%. It is launching an immediate independent review of its UK supply chain, led by lawyer Alison Levitt. The fashion retailer said it is also accelerating its independent third party supply chain review with ethical audit and compliance specialists Verisio and Bureau Veritas. In addition, boohoo said it will be making an initial commitment to invest an incremental GBP10 million to eradicate supply chain malpractice. The move comes after Next and ASOS dropped boohoo clothing from their websites after claims that the fast-fashion retailer sold clothes made in factories where staff were paid less than the minimum wage and worked in poor conditions. boohoo has had more than GBP1 billion wiped from its share value in the past two days after an article in the Sunday Times newspaper alleged that workers in a Leicester factory making clothes destined for boohoo were being paid as little as GBP3.50 an hour.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.